ArticleBritish journal of pharmacology2015

Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.